NYSE:NUVB

Nuvation Bio Stock Insider Trading

Healthcare > Biotechnology

Buy NUVB

*Your capital is at risk

$4.72

-0.180 (-3.67%)

At Close: Jun 03, 2026

Nuvation Bio Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 16.09. In total, the insiders bought 17.87M and sold 1.85M NUVB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	16.09
● Buy	17.87M shares
● Sell	1.85M shares
84% Buy Activity Strong Negative Correlation
Sell Signal Low Confidence Apr 06, 2026 Analysis Breakdown: Weakened by a contradictory positive Insider Power Score. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 21, 2025 Buy	Stock Option (Right to Buy) A-Award	Vernon W Anthony Director	Director	292 983 Value: $594.8K
May 21, 2025 Buy	Stock Option (Right to Buy) A-Award	Blickenstaff Kim D Director	Director	292 983 Value: $594.8K
May 21, 2025 Buy	Stock Option (Right to Buy) A-Award	Mashal Robert Director	Director	292 983 Value: $594.8K
May 21, 2025 Buy	Stock Option (Right to Buy) A-Award	Bazemore Robert B Director	Director	292 983 Value: $594.8K
May 21, 2025 Buy	Stock Option (Right to Buy) A-Award	Bazemore Robert B Director	Director	292 983 Value: $594.8K
May 21, 2025 Buy	Stock Option (Right to Buy) A-Award	Mashal Robert Director	Director	292 983 Value: $594.8K
May 21, 2025 Buy	Stock Option (Right to Buy) A-Award	Blickenstaff Kim D Director	Director	292 983 Value: $594.8K
May 21, 2025 Buy	Stock Option (Right to Buy) A-Award	Vernon W Anthony Director	Director	292 983 Value: $594.8K
May 21, 2025 Buy	Stock Option (Right to Buy) A-Award	Falberg Kathryn E Director	Director	292 983 Value: $594.8K
May 02, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Liu Dongfang Chief Medical Officer	Officer	20 000 Value: $38.8K
May 02, 2025 Buy	Class A Common Stock M-Exempt	Liu Dongfang Chief Medical Officer	Officer	20 000 Value: $38.8K
May 02, 2025 Sell	Class A Common Stock S-Sale	Liu Dongfang Chief Medical Officer	Officer	20 000 Value: $50.0K
May 02, 2025 Sell	Class A Common Stock S-Sale	Liu Dongfang Chief Medical Officer	Officer	20 000 Value: $50.0K
May 02, 2025 Buy	Class A Common Stock M-Exempt	Liu Dongfang Chief Medical Officer	Officer	20 000 Value: $38.8K
May 02, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Liu Dongfang Chief Medical Officer	Officer	20 000 Value: $38.8K
Apr 07, 2025 Buy	Class A Common Stock P-Purchase	Hung David President And CEO	CEO / President	300 000 Value: $487.5K
Apr 07, 2025 Buy	Class A Common Stock P-Purchase	Hung David President And CEO	CEO / President	300 000 Value: $487.5K
Apr 04, 2025 Buy	Class A Common Stock P-Purchase	Hung David President And CEO	CEO / President	200 000 Value: $332.7K
Apr 04, 2025 Buy	Class A Common Stock P-Purchase	Hung David President And CEO	CEO / President	200 000 Value: $332.7K
Apr 01, 2025 Buy	Class A Common Stock P-Purchase	Mashal Robert Director	Director	98 900 Value: $165.2K
Apr 01, 2025 Buy	Class A Common Stock P-Purchase	Mashal Robert Director	Director	1 100 Value: $2K
Apr 01, 2025 Buy	Class A Common Stock P-Purchase	Mashal Robert Director	Director	1 100 Value: $2K
Apr 01, 2025 Buy	Class A Common Stock P-Purchase	Mashal Robert Director	Director	98 900 Value: $165.2K
Feb 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Wentworth Kerry Chief Regulatory Officer	Officer	500 000 Value: $985.0K
Feb 28, 2025 Buy	Stock Option (Right to Buy) A-Award	Sjogren Colleen Chief Commercial Officer	Officer	500 000 Value: $985.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks